Fundraising Fox

Hydrocision

North Billerica, US · Delaware corporation

hydrocision.com ↗
Biotech

Founders & leadership

PK
PAUL KOWALSKIExecutive Officer
RA
RICHARD A. LYTLE, IIIExecutive Officer, Director
TD
THOMAS D. ABERTExecutive Officer
YX
YU XIAOTONGDirector
PV
PATRICIA VANBLARCOMExecutive Officer
LZ
LONG ZHANDirector
BG
BRYAN GRULKEDirector
ME
MARC E. GOLDBERGDirector
DW
DOUG WALLDirector
TW
TERRY WALLDirector
HW
HOWARD W. DONNELLYDirector

Reported raises · per SEC filings

Form D private placements
▶$2.5MraisedApr 2025 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • PAUL KOWALSKIExecutive Officer
  • DOUG WALLDirector
  • TERRY WALLDirector
  • LONG ZHANDirector
  • BRYAN GRULKEDirector
  • HOWARD W. DONNELLYDirector
  • RICHARD A. LYTLE, IIIExecutive Officer, Director
  • THOMAS D. ABERTExecutive Officer
  • MARC E. GOLDBERGDirector
Offering amount
$3.9M
Amount sold
$2.5M
Proceeds to insiders
$100.1K
First sale
Nov 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$3MraisedMar 2017 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • DOUG WALLDirector
  • TERRY WALLDirector
  • YU XIAOTONGDirector
  • PATRICIA VANBLARCOMExecutive Officer
  • PAUL KOWALSKIExecutive Officer
  • HOWARD DONNELLYDirector
  • MARC GOLDBERGDirector
Offering amount
$4M
Amount sold
$3M
First sale
Mar 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Non-dilutive funding · 1 SBIR/STTR award

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$300K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.